Contact Robert Melton, Esq. or submit a business inquiry online.
FDA
-
AI in Healthcare: HIPAA, FDA Oversight, and Legal Considerations
- June 6, 2026
- Posted by: allan
- Categories: AI Law, Healthcare Law
No Comments
Artificial intelligence is transforming healthcare delivery, clinical decision-making, and administrative operations — but it also creates a complex legal environment. This guide explains the key legal frameworks that govern AI in healthcare, including HIPAA, FDA regulation, and liability.
-
Building an Enterprise AI Governance Framework: From Policy to Defensible Implementation
A policy is a statement of intent — a governance framework is the organizational infrastructure that turns intent into auditable, defensible reality. This post is a practical guide to building an enterprise AI governance framework from the ground up.
October 12, 2026 Read more -
AI and Proxy Voting: How AI Is Disrupting Corporate Governance Advisory Services
JPMorgan’s launch of Proxy IQ — an internal AI platform replacing ISS and Glass Lewis for proxy voting decisions — marks the first large-scale deployment of AI as a direct substitute for human governance advisory services.
October 11, 2026 Read more -
AI Board Minutes and Corporate Records: Discovery, Privilege, and Governance Risks
AI-powered meeting tools capture board deliberations with unprecedented fidelity — but that same fidelity creates serious discovery, privilege, and governance risks that most companies have not yet addressed.
October 10, 2026 Read more -
Managing AI Governance Risks as Courts Expand Scrutiny of Corporate Decision-Making
Delaware’s Caremark doctrine — the board’s duty to oversee mission-critical risks — is being applied to AI governance as courts expand their scrutiny of corporate AI decision-making. This post explains what a legally defensible board-level AI governance structure must include in 2026 and what the liability exposure looks like when it is absent.
October 9, 2026 Read more
